Summary

The global medical gas and equipment market is projected to reach USD 30.05 billion by 2031 from USD 21.03 billion in 2025, at a CAGR of 6.2% during the forecast period.

The medical gas and equipment market is witnessing consistent growth. This is largely due to increased demand for respiratory care, critical care, and surgical procedures across healthcare systems worldwide. The rising prevalence of chronic diseases such as COPD, asthma, and cardiovascular disorders, along with a growing elderly population, has significantly increased dependence on medical gases and related delivery equipment. Moreover, the development and refurbishment of hospital buildings, ambulatory surgical centers, and home healthcare services, especially in developing countries, are leading to new medical gas infrastructure installations and upgrades. Furthermore, innovations in gas delivery systems, portable devices, and monitoring solutions are revolutionizing treatment efficiency and making care more accessible. Together, these factors are driving continued growth in the medical gas and equipment market.
“By type, the medical gases segment is expected to have the largest market share in the medical gas and equipment market.”
Medical gases represent the largest segment in the medical gas and equipment market by type, owing to their indispensable and constant use across nearly all healthcare settings. Gases such as oxygen, medical air, nitrous oxide, nitrogen, and carbon dioxide play a vital role in respiratory therapy, anesthesia, intensive care, emergency treatment, and a wide range of diagnostic and therapeutic procedures. While equipment is purchased or replaced on a one-time basis, medical gases are consumables that require a regular supply; hence, demand for them is consistently high. The escalating number of chronic disease cases, increasing surgical procedures, and rising hospital and ICU admissions continue to fuel medical gas consumption. Furthermore, the growth of home healthcare and long-term oxygen therapy, coupled with stringent regulatory requirements that guarantee uninterrupted gas availability in healthcare facilities, are among the reasons medical gases still hold the largest share of the overall medical gas and equipment market.
“By application, the therapeutic applications segment is expected to have the largest market share in the medical gas and equipment market.”
Therapeutic uses account for the largest share of the application segment in the medical gas and equipment market, as medical gases are of prime importance to the treatment and management of various acute and chronic conditions. Oxygen, nitrous oxide, and medical air are used in almost all cases of respiratory therapy, critical care, emergency medicine, anesthesia, and pain management, making them essential equipment in hospitals, clinics, and home care. With the rise in the number of people suffering from chronic respiratory and cardiovascular diseases, along with the increase in the elderly population, there has been a consequent demand for long-term, continuous therapeutic gas administration. In addition, more hospital admissions, higher surgical volumes, and the expanded use of home healthcare and long-term oxygen therapy further support the prominence of therapeutic applications. Consequently, the continuous, large-scale use of medical gases for patient treatment continues to drive the leading share of this segment in the medical gas and equipment market.
“The US is expected to grow at the highest CAGR for the North America medical gas and equipment market.”
The US market for medical gases and equipment is projected to have the highest CAGR in North America, driven by advanced healthcare infrastructure and high healthcare spending. Rising chronic respiratory and cardiovascular illnesses and an aging population are major factors behind substantial demand for medical gases such as oxygen and their delivery equipment. In addition, increased hospitalizations, growth in ICU facilities, and rising surgical volumes are accelerating the installation and upgrades of medical gas pipeline systems and equipment. The boom in home healthcare and the long-term oxygen therapy market, along with stringent patient safety regulations and compliance requirements, are propelling the market to grow faster. On top of that, ongoing technological progress and the presence of prominent medical gas manufacturers and service providers in the U.S. are helping the country maintain its position as the fastest-growing market in North America.
A breakdown of the primary participants (supply-side) for the medical gas and equipment market referred to for this report is provided below:
・By Company Type: Tier 1–35%, Tier 2–40%, and Tier 3–25%
・By Designation: C-level–45%, Director Level–35%, and Others–20%
・By Region: North America–27%, Europe–25%, Asia Pacific–30%, Latin America- 8%, Middle East & Africa-10% .
Prominent players in the medical gas and equipment market are Air Liquide (France), Linde Plc (Germany), Taiyo Nippon Sanso Corporation (Japan), Air Products and Chemicals Inc. (US), Atlas Copco AB (Sweden), GCE Group (Sweden), Messer SE & Co. KGaA (Germany), SOL Spa (Italy), Rotarex (Europe), Norco Inc. (US), Genstar Technologies (US), Southern Gas Limited (India), Calox Inc. (US), Ellenbarrie Industrial Gases (India), Steelman Gases Pvt. Ltd. (India), Butler Gas Products Company (US), SCI Analytical (US), Amico Group of Companies (US), Oxygen & Argon Works Ltd. (Israel), AOPL (India), Apex Medical Gas Inc. (US).
Research Coverage:
The report analyzes the medical gas and equipment market and aims to estimate the market size and future growth potential across various segments, including type, application, end user, and region. The report also includes a competitive analysis of the key players in this market, along with their company profiles, service offerings, recent developments, and key market strategies.
Reasons to Buy the Report
The report will provide market leaders and new entrants in this market with the closest available estimates of revenue for the overall medical gas and equipment market. It will help stakeholders understand the competitive landscape and gain insights to position their businesses more effectively and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides information on key market drivers, restraints, challenges, and opportunities.
This report provides insights into the following pointers:
・ Analysis of key drivers (rising demand for medical oxygen, increasing number of surgeries, growing elderly population, and rising demand for home healthcare), restraints (declining reimbursements for respiratory therapies, and global helium shortage), opportunities (expansion of healthcare industry, rising demand for pain management, and advancements in healthcare technology) and challenges (limited availability of medical gases, and high cost of medical gas equipment).
・Market Penetration: It includes extensive information on products offered by the major players in the global the medical gas and equipment market. The report includes various segments in type, application, end user and region.
・Product Enhancement/Innovation: Comprehensive details about new product launches and anticipated trends in the global medical gas and equipment market.
・Market Development: Thorough knowledge and analysis of the profitable rising markets by offering, application, end user and region.
・Market Diversification: Comprehensive information about newly launched products, expanding markets, current advancements, and investments in the global the medical gas and equipment market.
・Competitive Assessment: Thorough evaluation of the market shares, growth plans, offerings of products, and capacities of the major competitors in the global medical gas and equipment market.

ページTOPに戻る

Table of Contents

1 INTRODUCTION 35
1.1 STUDY OBJECTIVES 35
1.2 MARKET DEFINITION 35
1.3 STUDY SCOPE 36
1.3.1 MARKET SEGMENTATION & REGIONAL SCOPE 36
1.3.2 INCLUSIONS & EXCLUSIONS 37
1.3.3 YEARS CONSIDERED 37
1.3.4 CURRENCY CONSIDERED 38
1.4 STAKEHOLDERS 38
1.5 SUMMARY OF CHANGES 38
2 EXECUTIVE SUMMARY 40
2.1 KEY INSIGHTS & MARKET HIGHLIGHTS 40
2.2 KEY MARKET PARTICIPANTS: INSIGHTS & DEVELOPMENTS 45
2.3 DISRUPTIVE TRENDS SHAPING MARKET GROWTH 46
2.4 HIGH-GROWTH SEGMENTS & EMERGING FRONTIERS 47
2.5 SNAPSHOT: GLOBAL MARKET SIZE, GROWTH RATE, AND FORECAST 48
3 PREMIUM INSIGHTS 49
3.1 MEDICAL GAS AND EQUIPMENT MARKET OVERVIEW 49
3.2 ASIA PACIFIC MEDICAL GAS AND EQUIPMENT MARKET 50
3.3 MEDICAL GAS AND EQUIPMENT MARKET: REGIONAL MIX 51
3.4 MEDICAL GAS AND EQUIPMENT MARKET: GEOGRAPHICAL GROWTH OPPORTUNITIES 51
3.5 MEDICAL GAS AND EQUIPMENT MARKET: DEVELOPING VS. DEVELOPED MARKETS 52
4 MARKET OVERVIEW 53
4.1 INTRODUCTION 53
4.2 MARKET DYNAMICS 53
4.2.1 DRIVERS 54
4.2.1.1 Increasing demand for medical oxygen 54
4.2.1.2 Growing number of surgeries 54
4.2.1.3 Expansion of geriatric population and subsequent rise in chronic diseases 55
4.2.1.4 Shift toward home healthcare settings 55
4.2.2 RESTRAINTS 56
4.2.2.1 Declining reimbursements for respiratory therapies 56
4.2.2.2 Strict regulatory and safety compliance requirements 56
 
4.2.3 OPPORTUNITIES 57
4.2.3.1 Expansion of healthcare industry 57
4.2.3.2 Surge in demand for pain management solutions 57
4.2.3.3 Growing advancements in healthcare technologies 58
4.2.4 CHALLENGES 58
4.2.4.1 Limited availability of medical gases 58
4.2.4.2 High cost of medical gas equipment 59
4.3 UNMET NEEDS & WHITE SPACES 59
4.3.1 UNMET NEEDS IN MEDICAL GAS AND EQUIPMENT MARKET 59
4.3.2 WHITE SPACE OPPORTUNITIES 60
4.4 INTERCONNECTED MARKETS & CROSS-SECTOR OPPORTUNITIES 61
4.4.1 INTERCONNECTED MARKETS 61
4.4.2 CROSS-SECTOR OPPORTUNITIES 62
4.5 STRATEGIC MOVES BY TIER-1/2/3 PLAYERS 63
5 INDUSTRY TRENDS 65
5.1 PORTER’S FIVE FORCES ANALYSIS 65
5.1.1 THREAT OF NEW ENTRANTS 66
5.1.2 THREAT OF SUBSTITUTES 66
5.1.3 BARGAINING POWER OF SUPPLIERS 66
5.1.4 BARGAINING POWER OF BUYERS 66
5.1.5 INTENSITY OF COMPETITIVE RIVALRY 66
5.2 MACROECONOMIC OUTLOOK 66
5.2.1 INTRODUCTION 66
5.2.2 GDP TRENDS & FORECAST 67
5.2.3 TRENDS IN RESPIRATORY CARE DEVICES INDUSTRY 68
5.2.4 TRENDS IN MEDICAL NITROUS OXIDE INDUSTRY 69
5.3 SUPPLY CHAIN ANALYSIS 69
5.4 VALUE CHAIN ANALYSIS 70
5.5 ECOSYSTEM ANALYSIS 71
5.6 PRICING ANALYSIS 72
5.6.1 AVERAGE SELLING PRICE TREND OF MEDICAL GASES, BY KEY PLAYER (2023–2025) 72
5.6.2 AVERAGE SELLING PRICE TREND OF MEDICAL GASES AND EQUIPMENT,
BY REGION (2023–2025) 73
5.7 TRADE DATA ANALYSIS 74
5.7.1 IMPORT DATA 74
5.7.2 EXPORT DATA 75
5.8 KEY CONFERENCES & EVENTS, 2026–2027 75
5.9 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 76
5.10 INVESTMENT & FUNDING SCENARIO 77
 
5.11 CASE STUDY ANALYSIS 77
5.11.1 CASE STUDY 1: ADOPTION OF COMPUTERIZED TRACKING SYSTEM FOR IMPROVED PATIENT SAFETY AND STREAMLINED COMPLIANCE DOCUMENTATION 77
5.11.2 CASE STUDY 2: IMPLEMENTATION OF COMPREHENSIVE ALARM MANAGEMENT SYSTEM FOR RESPONSIBLE SURVEILLANCE 78
5.11.3 CASE STUDY 3: DEVELOPMENT OF PRESSURE SWING ADSORPTION PLANTS TO MEET INCREASING NEEDS OF LIQUID MEDICAL OXYGEN 78
5.12 IMPACT OF 2025 US TARIFFS ON MEDICAL GAS AND EQUIPMENT MARKET 79
5.12.1 INTRODUCTION 79
5.12.2 KEY TARIFF RATES 79
5.12.3 PRICE IMPACT ANALYSIS 80
5.12.4 IMPACT ON COUNTRY/REGION 81
5.12.4.1 US 81
5.12.4.2 Europe 81
5.12.4.3 Asia Pacific 81
5.12.4.4 Latin America 81
5.12.4.5 Middle East & Africa/GCC 81
5.12.5 IMPACT ON END USER INDUSTRIES 82
6 TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS 83
6.1 KEY EMERGING TECHNOLOGIES 83
6.1.1 SMART MEDICAL GAS MONITORING SYSTEMS 83
6.1.2 AI-BASED PREDICTIVE MAINTENANCE 83
6.1.3 DIGITAL TWIN TECHNOLOGY 83
6.2 COMPLEMENTARY TECHNOLOGIES 84
6.2.1 MEDICAL GAS PIPELINE SYSTEMS (MGPS) 84
6.3 ADJACENT TECHNOLOGIES 84
6.3.1 HEALTHCARE IOT (IOMT) 84
6.4 TECHNOLOGY/PRODUCT ROADMAP 85
6.4.1 SHORT TERM (2025–2027) | FOUNDATION & EARLY COMMERCIALIZATION 85
6.4.2 MID TERM (2027–2030) | EXPANSION & STANDARDIZATION 86
6.4.3 LONG TERM (2030–2035+) | MASS COMMERCIALIZATION & DISRUPTION 87
6.5 PATENT ANALYSIS 89
6.6 FUTURE APPLICATIONS OF MEDICAL GAS AND EQUIPMENT 90
6.7 IMPACT OF AI/GEN AI ON MEDICAL GAS AND EQUIPMENT MARKET 92
6.7.1 TOP USE CASES & MARKET POTENTIAL 92
6.7.2 BEST PRACTICES IN MEDICAL GAS AND EQUIPMENT PROCESSING 93
6.7.3 CASE STUDIES OF AI IMPLEMENTATION IN MEDICAL GAS AND EQUIPMENT MARKET 93
6.7.4 INTERCONNECTED ADJACENT ECOSYSTEMS & IMPACT ON MARKET PLAYERS 94
6.7.5 CLIENTS’ READINESS TO ADOPT GENERATIVE AI IN MEDICAL GAS AND EQUIPMENT MARKET 95
7 REGULATORY LANDSCAPE 97
7.1 REGIONAL REGULATIONS & COMPLIANCE 97
7.1.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 97
7.1.2 INDUSTRY STANDARDS 101
7.2 CERTIFICATIONS, LABELING, AND ECO-STANDARDS 102
8 CUSTOMER LANDSCAPE & BUYER BEHAVIOR 103
8.1 DECISION-MAKING PROCESS 103
8.2 BUYER STAKEHOLDERS & BUYING EVALUATION CRITERIA 104
8.2.1 KEY STAKEHOLDERS IN BUYING PROCESS 104
8.2.2 BUYING CRITERIA 105
8.3 ADOPTION BARRIERS & INTERNAL CHALLENGES 105
8.4 UNMET NEEDS FROM VARIOUS END-USE INDUSTRIES 106
8.5 MARKET PROFITABILITY 107
8.5.1 REVENUE POTENTIAL 107
8.5.2 COST DYNAMICS 107
8.5.3 MARGIN OPPORTUNITIES IN KEY APPLICATIONS 108
9 MEDICAL GAS AND EQUIPMENT MARKET, BY TYPE 109
9.1 INTRODUCTION 110
9.2 MEDICAL GASES 110
9.2.1 PURE MEDICAL GASES 111
9.2.1.1 Oxygen 113
9.2.1.1.1 Increasing prevalence of respiratory diseases to accelerate growth 113
9.2.1.2 Carbon dioxide 115
9.2.1.2.1 Evolving technologies and treatment methods in healthcare sector to facilitate growth 115
9.2.1.3 Nitrogen 116
9.2.1.3.1 Growing utilization in reproductive medicine and regenerative medicine to drive market 116
9.2.1.4 Nitrous oxide 118
9.2.1.4.1 Increasing emphasis on patient comfort to contribute to market growth 118
9.2.1.5 Medical air 120
9.2.1.5.1 Growing need for advanced healthcare infrastructure to boost market 120
9.2.1.6 Other pure medical gases 122
 
9.2.2 MEDICAL GAS MIXTURES 124
9.2.2.1 Blood gas mixtures 126
9.2.2.1.1 Growing integration with electronic health records and other diagnostic systems to boost market 126
9.2.2.2 Lung diffusion mixtures 127
9.2.2.2.1 Rising importance of early detection and management of lung disorders to favor growth 127
9.2.2.3 Nitrous oxide-oxygen mixtures 128
9.2.2.3.1 Expanding role in anesthesia and pain management to sustain growth 128
9.2.2.4 Carbon dioxide-oxygen mixtures 130
9.2.2.4.1 Growing adoption of minimally invasive surgical techniques to propel market 130
9.2.2.5 Laser gas mixtures 131
9.2.2.5.1 Increasing applications in dermatology, ophthalmology, and oncology to stimulate growth 131
9.2.2.6 Anaerobic gas mixtures 132
9.2.2.6.1 Increasing adoption of advanced equipment in clinical and research settings to promote growth 132
9.2.2.7 Aerobic gas mixtures 133
9.2.2.7.1 Booming geriatric population and rising pollution levels to drive market 133
9.2.2.8 Helium-oxygen mixtures 134
9.2.2.8.1 Rising benefits in emergency and routine medical care to expedite growth 134
9.2.2.9 Other medical gas mixtures 136
9.3 MEDICAL GAS EQUIPMENT 137
9.3.1 GAS DELIVERY SYSTEMS 138
9.3.1.1 Rising focus on patient stability and recovery to promote growth 138
9.3.2 GAS SUPPLY EQUIPMENT 140
9.3.2.1 Medical gas cylinders 141
9.3.2.1.1 Growing demand for portable oxygen delivery and emergency medical preparedness to propel market 141
9.3.2.2 Bulk storage systems 143
9.3.2.2.1 Rising healthcare infrastructure expansion and increasing medical gas consumption to propel market 143
9.3.2.3 Liquid oxygen systems 144
9.3.2.3.1 Increasing demand for high-volume oxygen supply and critical care services to propel market 144
9.3.2.4 Cryogenic tanks 145
9.3.2.4.1 Growing adoption of centralized medical gas storage and rising demand for large-capacity gas reserves to propel market 145
9.3.2.5 Vacuum systems 146
9.3.2.5.1 Growing focus on infection control and complex surgical therapies to propel market 146
9.3.2.6 Medical air compressors 148
9.3.2.6.1 Increasing demand for advanced healthcare services to augment growth 148
9.3.3 GAS REGULATION & MONITORING EQUIPMENT 149
9.3.3.1 Regulators 151
9.3.3.1.1 Rising focus on treatment efficacy and patient safety to augment growth 151
9.3.3.2 Flowmeters 152
9.3.3.2.1 Increasing use in anesthesia, respiratory therapy, and neonatal care applications to boost market 152
9.3.3.3 Valves with integrated pressure regulators (VIPRs) 153
9.3.3.3.1 Rising focus on improved patient care and streamlined operations to favor growth 153
9.3.3.4 Pressure gauges 154
9.3.3.4.1 Increasing emphasis on medical gas safety and real-time pressure monitoring to propel market 154
9.3.3.5 Gas monitoring systems 155
9.3.3.5.1 Need for safe and effective delivery of medical gases to aid growth 155
9.3.4 OTHER EQUIPMENT & ACCESSORIES 157
10 MEDICAL GAS AND EQUIPMENT MARKET, BY APPLICATION 159
10.1 INTRODUCTION 160
10.2 THERAPEUTIC APPLICATIONS 160
10.2.1 RESPIRATORY THERAPIES 162
10.2.1.1 Increasing accessibility of portable and home-based respiratory therapy equipment to boost market 162
10.2.2 CARDIOVASCULAR THERAPIES 163
10.2.2.1 Sedentary lifestyles and poor dietary habits to sustain growth 163
10.2.3 ANESTHESIA DELIVERY 165
10.2.3.1 Growing incidence of age-related health conditions to fuel market 165
10.2.4 CRYOSURGERY APPLICATIONS 166
10.2.4.1 Increasing demand for minimally invasive and cost-effective treatments to promote growth 166
10.2.5 OTHER THERAPEUTIC APPLICATIONS 167
10.3 PHARMACEUTICAL MANUFACTURING & RESEARCH APPLICATIONS 168
10.3.1 BOOMING BIOPHARMACEUTICAL RESEARCH & DEVELOPMENT INITIATIVES TO ENCOURAGE GROWTH 168
10.4 DIAGNOSTIC APPLICATIONS 169
10.4.1 MEDICAL IMAGING 171
10.4.1.1 Rising demand for high-resolution imaging and advanced diagnostic capabilities to propel market 171
10.4.2 GENERAL LABORATORY APPLICATIONS 172
10.4.2.1 Need for efficient functioning of equipment and compliance with regulatory standards to drive market 172
10.5 OTHER APPLICATIONS 174
11 MEDICAL GAS AND EQUIPMENT MARKET, BY END USER 176
11.1 INTRODUCTION 177
11.2 HOSPITALS & CLINICS 177
11.2.1 BOOMING OUTPATIENT CARE AND SPECIALIZED CLINIC SERVICES TO AUGMENT GROWTH 177
11.3 HOME HEALTHCARE 179
11.3.1 GROWING SHIFT TOWARD HOME HEALTHCARE TO SUPPORT MARKET 179
11.4 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 180
11.4.1 ONGOING ADVANCEMENTS IN PERSONALIZED MEDICINE, GENE THERAPY, AND IMMUNOTHERAPY TO ENCOURAGE GROWTH 180
11.5 ACADEMIC & RESEARCH INSTITUTIONS 181
11.5.1 GROWING IMPORTANCE OF HIGH-QUALITY EDUCATION AND TRAINING TO BOOST MARKET 181
11.6 OTHER END USERS 182
12 MEDICAL GAS AND EQUIPMENT MARKET, BY REGION 184
12.1 INTRODUCTION 185
12.2 NORTH AMERICA 185
12.2.1 US 191
12.2.1.1 Presence of key players to sustain growth 191
12.2.2 CANADA 196
12.2.2.1 Stringent regulatory compliance to favor market growth 196
12.3 EUROPE 202
12.3.1 GERMANY 208
12.3.1.1 Growing adoption of advanced healthcare technologies to fuel market 208
12.3.2 UK 213
12.3.2.1 Growing aging population to drive market 213
12.3.3 FRANCE 218
12.3.3.1 Well-established healthcare system to support growth 218
12.3.4 SPAIN 223
12.3.4.1 High burden of chronic diseases to augment growth 223
12.3.5 ITALY 228
12.3.5.1 Rising demand for therapeutic gases to aid growth 228
12.3.6 REST OF EUROPE 233
12.4 ASIA PACIFIC 239
12.4.1 JAPAN 245
12.4.1.1 Dominant elderly population to propel market 245
12.4.2 CHINA 250
12.4.2.1 Strong public healthcare infrastructure to stimulate growth 250
 
12.4.3 INDIA 255
12.4.3.1 Growing incidence of cardiovascular diseases to spur growth 255
12.4.4 AUSTRALIA 260
12.4.4.1 Robust Medicare program to facilitate growth 260
12.4.5 SOUTH KOREA 265
12.4.5.1 Increasing cases of heart disease, obesity, cancer, and diabetes to drive market 265
12.4.6 REST OF ASIA PACIFIC 270
12.5 LATIN AMERICA 275
12.5.1 BRAZIL 281
12.5.1.1 Increasing healthcare spending to contribute to market growth 281
12.5.2 MEXICO 286
12.5.2.1 Expanding pharmaceutical industry to propel market 286
12.5.3 REST OF LATIN AMERICA 291
12.6 MIDDLE EAST & AFRICA 296
12.6.1 FAVORABLE GOVERNMENT INITIATIVES FOR INFRASTRUCTURE DEVELOPMENT TO DRIVE MARKET 296
12.6.2 GCC COUNTRIES 302
12.6.2.1 Increasing prevalence of cardiovascular diseases to augment growth 302
12.6.3 REST OF MIDDLE EAST & AFRICA 307
13 COMPETITIVE LANDSCAPE 313
13.1 INTRODUCTION 313
13.2 KEY PLAYER STRATEGY/RIGHT TO WIN 313
13.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN MEDICAL GAS AND EQUIPMENT MARKET 313
13.3 REVENUE ANALYSIS, 2021–2025 315
13.4 MARKET SHARE ANALYSIS, 2025 316
13.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025 318
13.5.1 STARS 318
13.5.2 EMERGING LEADERS 318
13.5.3 PERVASIVE PLAYERS 318
13.5.4 PARTICIPANTS 319
13.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2025 320
13.5.5.1 Company footprint 320
13.5.5.2 Region footprint 321
13.5.5.3 Type footprint 322
13.5.5.4 Application footprint 323
13.5.5.5 End-user footprint 324
13.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2025 326
13.6.1 PROGRESSIVE COMPANIES 326
13.6.2 RESPONSIVE COMPANIES 326
13.6.3 DYNAMIC COMPANIES 326
13.6.4 STARTING BLOCKS 326
13.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2025 328
13.6.5.1 Detailed list of key startups/SMEs 328
13.6.5.2 Competitive benchmarking of startups/SMEs 329
13.7 BRAND/PRODUCT COMPARISON 330
13.8 COMPANY VALUATION & FINANCIAL METRICS 331
13.8.1 FINANCIAL METRICS 331
13.8.2 COMPANY VALUATION 331
13.9 COMPETITIVE SCENARIO 332
13.9.1 DEALS 332
13.9.2 EXPANSIONS 333
13.9.3 THER DEVELOPMENTS 333
14 COMPANY PROFILES 334
14.1 KEY PLAYERS 334
14.1.1 LINDE PLC 334
14.1.1.1 Business overview 334
14.1.1.2 Products offered 335
14.1.1.3 Recent developments 336
14.1.1.3.1 Expansions 336
14.1.1.4 MnM view 337
14.1.1.4.1 Right to win 337
14.1.1.4.2 Strategic choices 337
14.1.1.4.3 Weaknesses & competitive threats 337
14.1.2 AIR LIQUIDE 338
14.1.2.1 Business overview 338
14.1.2.2 Products offered 339
14.1.2.3 Recent developments 341
14.1.2.3.1 Deals 341
14.1.2.3.2 Expansions 341
14.1.2.3.3 Other developments 342
14.1.2.4 MnM view 342
14.1.2.4.1 Right to win 342
14.1.2.4.2 Strategic choices 342
14.1.2.4.3 Weaknesses & competitive threats 342
14.1.3 MESSER SE & CO. KGAA 343
14.1.3.1 Business overview 343
14.1.3.2 Products offered 344
14.1.3.3 Recent developments 345
14.1.3.3.1 Deals 345
14.1.3.3.2 Expansions 345
 
14.1.3.4 MnM view 346
14.1.3.4.1 Right to win 346
14.1.3.4.2 Strategic choices 346
14.1.3.4.3 Weaknesses & competitive threats 346
14.1.4 AIR PRODUCTS AND CHEMICALS, INC. 347
14.1.4.1 Business overview 347
14.1.4.2 Products offered 348
14.1.4.3 MnM view 349
14.1.4.3.1 Right to win 349
14.1.4.3.2 Strategic choices 349
14.1.4.3.3 Weaknesses & competitive threats 349
14.1.5 NIPPON SANSO HOLDINGS CORPORATION 350
14.1.5.1 Business overview 350
14.1.5.2 Products offered 351
14.1.5.3 Recent developments 352
14.1.5.3.1 Deals 352
14.1.5.4 MnM view 352
14.1.5.4.1 Right to win 352
14.1.5.4.2 Strategic choices 352
14.1.5.4.3 Weaknesses & competitive threats 352
14.1.6 ATLAS COPCO AB 353
14.1.6.1 Business overview 353
14.1.6.2 Products offered 354
14.1.6.3 Recent developments 355
14.1.6.3.1 Deals 355
14.1.7 GCE GROUP 357
14.1.7.1 Business overview 357
14.1.7.2 Products offered 357
14.1.7.3 Recent developments 359
14.1.7.3.1 Deals 359
14.1.8 SOL SPA 360
14.1.8.1 Business overview 360
14.1.8.2 Products offered 361
14.1.8.3 Recent developments 362
14.1.8.3.1 Deals 362
14.1.8.3.2 Expansions 363
14.1.9 ROTAREX 364
14.1.9.1 Business overview 364
14.1.9.2 Products offered 364
14.1.10 NORCO INC. 367
14.1.10.1 Business overview 367
14.1.10.2 Products offered 367
14.1.11 GENSTAR TECHNOLOGIES 368
14.1.11.1 Business overview 368
14.1.11.2 Products offered 368
14.1.12 SOUTHERN GAS LIMITED 371
14.1.12.1 Business overview 371
14.1.12.2 Products offered 372
14.1.13 DRÄGERWERK AG & CO. KGAA 373
14.1.13.1 Business overview 373
14.1.13.2 Products offered 375
14.1.14 CALOX INC. 376
14.1.14.1 Business overview 376
14.1.14.2 Products offered 376
14.1.15 PT SAMATOR INDO GAS TBK 377
14.1.15.1 Business overview 377
14.1.15.2 Products offered 378
14.2 OTHER PLAYERS 380
14.2.1 BUTLER GAS PRODUCTS COMPANY 380
14.2.2 AMICO GROUP OF COMPANIES 381
14.2.3 AIMS OXYGEN PVT LTD. (AOPL) 382
14.2.4 APEX MEDICAL GAS INC. 383
14.2.5 CHENGDU TAIYO INDUSTRIAL GASES CO., LTD. 384
14.2.6 STEELMAN GASES PVT. LTD. 385
14.2.7 CARBIDE AND CHEMICALS 386
14.2.8 HOLSTON GASES 387
14.2.9 MEC MEDICAL LTD. 388
14.2.10 PRECISION UK 389
15 RESEARCH METHODOLOGY 390
15.1 RESEARCH DATA 390
15.1.1 SECONDARY DATA 391
15.1.1.1 Key data from secondary sources 391
15.1.2 PRIMARY DATA 392
15.1.2.1 Key data from primary sources 393
15.1.2.2 Key industry insights 393
15.2 MARKET SIZE ESTIMATION 393
15.2.1 BOTTOM-UP APPROACH 394
15.2.2 TOP-DOWN APPROACH 394
15.2.3 BASE NUMBER ESTIMATION 395
15.3 MARKET FORECAST APPROACH 397
15.4 MARKET BREAKDOWN & DATA TRIANGULATION 399
 
15.5 ASSUMPTIONS 400
15.5.1 MARKET SHARE ASSUMPTIONS 400
15.5.2 RESEARCH ASSUMPTIONS 400
15.6 FACTOR ANALYSIS 401
15.7 RISK ASSESSMENT 401
15.8 METHODOLOGY-RELATED LIMITATIONS 402
16 APPENDIX 403
16.1 DISCUSSION GUIDE 403
16.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 410
16.3 CUSTOMIZATION OPTIONS 412
16.4 RELATED REPORTS 412
16.5 AUTHOR DETAILS 413